Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Market sentiment signals for Xeris Biopharma Holdings (XERS): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
8 analysts
Options Flow (P/C)
—
Avg Consensus PT
$14
-20.2%
Highest Price Target
$21
+22.0%
Lowest Price Target
$6
-65.2%
Short Interest
5.1%
Rising — Bearish
Insider Activity (30d)
Net Seller
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Nov 11, 2026 | Barclays | Glen Santangelo— | +4.5% | $14 → $18 | Maintained | Overweight |
| Nov 6, 2026 | Oppenheimer | Leland Gershell— | +22.0% | $18 → $21 | Maintained | Outperform |